An open label, two period, fixed sequence study evaluating the safety and pharmacokinetic interactions between grazoprevir and the oral contraceptives ethinyl estradiol/levonorgestrel in healthy adult women
Latest Information Update: 06 Apr 2017
At a glance
- Drugs Grazoprevir (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- 06 Apr 2017 New trial record
- 24 Feb 2017 Results from a pooled analysis from MK-5172-046 and MK-8742-013 studies, published in the European Journal of Clinical Pharmacology